ABL Diagnostics Société anonyme (EPA:ABLD)
France · Delayed Price · Currency is EUR 3.380
-0.520 (-13.33%)
May 14, 2026, 5:35 PM CET
EPA:ABLD Market Cap
EPA:ABLD has a market cap or net worth of €62.84 million as of May 14, 2026. Its market cap has decreased by -29.73% in one year.
Market Cap
62.84M
Enterprise Value
64.61M
Revenue
6.23M
Ranking
n/a
PE Ratio
135.63
Stock Price
€3.38
Market Cap Chart
Since November 17, 2000, EPA:ABLD's market cap has increased from 2.51M to 62.84M, an increase of 2,405.65%. That is a compound annual growth rate of 13.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 14, 2026 | 54.46M | 12.67% |
| Dec 31, 2025 | 48.34M | 21.95% |
| Dec 31, 2024 | 39.64M | -74.64% |
| Dec 29, 2023 | 156.30M | 3,819.50% |
| Dec 30, 2021 | 3.99M | 34.75% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sanofi | 88.05B |
| EssilorLuxottica Société anonyme | 76.39B |
| Sartorius Stedim Biotech | 15.59B |
| Ipsen | 13.60B |
| Eurofins-Cerep | 80.20M |
| AB Science | 73.78M |
| Novacyt | 57.75M |
| Klea Holding | 56.36M |